Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477594
Status:
COMPLETED
Last Update Posted:
2016-09-09
First Post:
2007-05-22
Brief Title:
Open Label Extension of ISIS 301012 Mipomersen to Treat Familial Hypercholesterolemia
Sponsor:
Kastle Therapeutics LLC
Organization:
Kastle Therapeutics LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lipid Metabolism Disorders |
| Lipid Metabolism Inborn Errors |
| Hypercholesterolemia Autosomal Dominant |
| Hyperlipidemias |
| Metabolic Diseases |
| Hyperlipoproteinemia Type II |
| Metabolism Inborn Errors |
| Genetic Diseases Inborn |
| Infant Newborn Diseases |
| Metabolic Disorder |
| Congenital Abnormalities |
| Hypercholesterolemia |
| Hyperlipoproteinemias |
| Dyslipidemias |